J Korean Ophthalmol Soc.  2002 Oct;43(10):1847-1851.

Ocular Manifestations of Patients with Rheumatic Disease and Dry Eye Symptom

Affiliations
  • 1Department of Ophthalmology, College of Medical, Soonchunhyang University Chunan Hospital, Korea.ophljh@sparc.schch.co.kr

Abstract

PURPOSE: To evaluate the ocular manifestations of patients with rheumatic disease and dry eye symptom.
METHODS
We analized the results of ocular examinations and complications of 78 rheumatoid disease patients who were refered for dry eye symptom from the general medicine from 1998, May to 1999, May.
RESULTS
Ocular complications were seen in 47 patients (60.3%). Keratoconjunctivitis sicca was the most common ocular finding (48.7%). Other lesions were episcleritis, scleritis, peripheral corneal erosion, marginal keratitis, stromal corneal opacity, and so on. Thirty six patients (46.2%) showed sero-positivity for RA, ANA or CRP. The result was 6.87+/-4.44 mm (mean+/-standard deviation) in Schirmer test,6.64+/-2.27 sec in Tear Film Break Up Time (TBUT). Among sero-positive patients, Schirmer test was 5.46+/-4.05 mm and TBUT was 5.64+/-2.38 sec, while among sero-negatives the result was 8.21+/-4.33 mm, 7.40+/-1.89 sec respectively. It was statistically significant (P< 0.05). Schirmer test was 4.60+/-3.55 mm in RA positive, 2.50+/-1.60 mm in RA and ANA positive, 7.35+/-4.92 mm in CRP positive. TBUT was 5.57+/-2.39 sec, 4.00+/-1.31 sec, 5.69+/-2.04 sec in each group.
CONCLUSIONS
Ocular complications were increased in rheumatoid patients, especially with sero-positive for RA, ANA or CRP. The results of Schirmer test and TBUT were most decreased in patients with RA and ANA positivity.

Keyword

ANA; CRP; Rheumatoid factor; Rheumatoid disease

MeSH Terms

Corneal Opacity
Humans
Keratitis
Keratoconjunctivitis Sicca
Rheumatic Diseases*
Rheumatoid Factor
Scleritis
Tears
Rheumatoid Factor
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr